Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

VISMODEGIB for Neoplasm skin: Side Effects & Safety Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

There are 36 adverse event reports in the FDA FAERS database where VISMODEGIB was used for Neoplasm skin.

Most Reported Side Effects for VISMODEGIB

Side Effect Reports % Deaths Hosp.
Muscle spasms 1,937 23.8% 24 110
Alopecia 1,330 16.4% 28 81
Ageusia 958 11.8% 7 49
Fatigue 899 11.1% 20 78
Dysgeusia 706 8.7% 18 40
Weight decreased 688 8.5% 19 59
Nausea 669 8.2% 8 72
Decreased appetite 662 8.1% 21 69
Death 657 8.1% 641 23
Diarrhoea 446 5.5% 16 48
Constipation 361 4.4% 3 31
Off label use 335 4.1% 24 24
Asthenia 274 3.4% 14 52
Arthralgia 264 3.3% 0 20
No adverse event 247 3.0% 1 0

Other Indications for VISMODEGIB

Basal cell carcinoma (5,329) Product used for unknown indication (1,417) Skin cancer (452) Basal cell naevus syndrome (129) Neoplasm malignant (124) Congenital anomaly (54) Medulloblastoma (52) Squamous cell carcinoma of skin (42) Malignant melanoma (38) Neoplasm (36)

Other Drugs Used for Neoplasm skin

DUPILUMAB (22) PAZOPANIB (19) PEXIDARTINIB (18) APREMILAST (8) LENALIDOMIDE (7) SORAFENIB (5) TRAMETINIB DIMETHYL SULFOXIDE (5)

Related Pages

VISMODEGIB Full Profile All Neoplasm skin Drugs VISMODEGIB Demographics VISMODEGIB Timeline